Latest Breaking News On - Eastern cooperative oncology group performance status - Page 1 : comparemela.com

Qilu Pharmaceutical Showcases QL1706 Clinical Trial Outcomes in Oral Presentation at ESGO 2024

Wearable Activity Tracker Data Enhance Patient Assessment in Lung Cancer

This analysis included 119 patients with advanced lung cancer, who were evaluated on 3 facets of physical activity over 14 days of using the amuelink wearable device from Sony: metabolic equivalent tasks, distance walked, and steps taken.

Poor Well-Being Scores Linked to Early Treatment Stoppage in Multiple Myeloma

Investigators used the Functional Assessment of Cancer Therapy-General General Physical Wellbeing Scale to collect data on patient-reported treatment-related adverse effects, to provide clinicians guidance on predicting risk of early treatment discontinuation among ECOG-ACRIN E1A11 trial participants.

Aerobic Exercise, Tai Chi Improved Sleep in Patients With Lung Cancer

Improved psychological distress and physical function were among the benefits of doing aerobic exercise and tai chi as a patient with lung cancer.

SUMMIT: Bezuclastinib Demonstrates Reduction in NonAdvSM Symptoms

Bezuclastinib, a targeted oral therapy, shows promise in reducing disease burden and improving symptoms by 50% or more in nonadvanced systemic mastocytosis patients, as revealed in the phase 2 SUMMIT trial data presented at ASH 2023.